News|Articles|October 2, 2002
- Pharmaceutical Technology-10-02-2002
- Volume 26
- Issue 10
Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook
Author(s)Jim Miller
The European Union is attempting to reform its current business environment in hopes of restoring its role in the lobal R&D sector.
Advertisement
Articles in this issue
about 23 years ago
FDA Launches Major Review of CGMPsabout 23 years ago
Understanding Pharmaceutical Flowsabout 23 years ago
Cyclodextrins as Sustained-Release CarriersNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
2
Everything to Know About Pharmaceutical Tariffs in 2025
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
